Eating Disorders News and Research

Latest Eating Disorders News and Research

Vertex announces positive interim results from telaprevir Phase 2 study in patients with HCV, HIV

Vertex Pharmaceuticals Incorporated announced today interim results from an ongoing, two-part, Phase 2 study evaluating telaprevir in combination with pegylated-interferon and ribavirin compared to pegylated-interferon and ribavirin alone in people who are infected with both genotype 1 hepatitis C virus and human immunodeficiency virus, also known as HCV-HIV co-infection.

3 Mar 2011

Brain's reward/motivation circuits linked to compulsive overeating

A brain imaging study at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory reveals a subtle difference between ordinary obese subjects and those who compulsively overeat, or binge: In binge eaters but not ordinary obese subjects, the mere sight or smell of favorite foods triggers a spike in dopamine - a brain chemical linked to reward and motivation.

1 Mar 2011

Onyx, Bayer initiate patient enrollment in Nexavar Phase 3 trial for breast cancer treatment

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in a Phase 3 randomized, double-blind, placebo-controlled trial evaluating Nexavar tablets in combination with the oral chemotherapeutic agent, capecitabine, versus placebo plus capecitabine for the treatment of patients with advanced breast cancer.

24 Feb 2011

New study: Cannabis ingredient can improve appetites and sense of taste in cancer patients

The active ingredient in cannabis can improve the appetites and sense of taste in cancer patients, according to a new study published online in the cancer journal, Annals of Oncology today.

23 Feb 2011

Online Negative Enabling Support Group embraces anorexia as a choice

It can be a helpless and heartbreaking situation for families as they try to confront a family member with an eating disorder. What they may not know is that there's a society on the Internet that is dedicated to thwarting any recovery from this dangerous and possibly fatal behavior.

23 Feb 2011

Eating tissue to stay thin

In a recent interview on CNN, Janet Jackson talks about the extreme measures some women in Hollywood take to achieve and maintain a thin body. She says some are even eating Kleenex to stay full so they don't feel hungry. Kimberly Dennis, M.D., and Medical Director at Timberline Knolls Residential Treatment Center, a residential treatment center for eating disorders and addictions, warns about the dangers of this behavior, and says there might be deeper problems hidden below the surface.

19 Feb 2011

Study: Women with anorexia draw themselves with prominently different characteristics

Women suffering from anorexia or bulimia draw themselves with prominently different characteristics than women who do not have eating disorders and who are considered of normal weight. This has been revealed in a new joint study from the University of Haifa, Soroka University Medical Center and Achva Academic College, Israel, published in The Arts in Psychotherapy.

14 Feb 2011

Urocortin system plays central role in regulating stress responses

Post-traumatic stress disorder can affect soldiers after combat or ordinary people who have undergone harrowing experiences. Of course, feelings of anxiety are normal and even desirable - they are part of what helps us survive in a world of real threats. But no less crucial is the return to normal - the slowing of the heartbeat and relaxation of tension - after the threat has passed.

9 Feb 2011

Study reveals Facebook users may face risk of developing eating disorders

The same has been found with regard to exposure to music and fashion on the Internet, and to harmful programs on TV. The study also reveals that the risk of developing eating disorders in adolescent girls is moderated when there is more parental supervision over viewing habits.

8 Feb 2011

Phase II results of VELCADE in patients with aggressive lymphoma published in Journal of Clinical Oncology

Millennium: The Takeda Oncology Company today announced that Phase II results of a clinical trial examining VELCADE (bortezomib) in patients with previously untreated aggressive lymphoma were published in the Journal of Clinical Oncology.

5 Feb 2011

GSA commends '2010 Dietary Guidelines for Americans'

The Gerontological Society of America (GSA) - the nation's largest interdisciplinary organization devoted to the field of aging - commends the federal government's recent release of the "2010 Dietary Guidelines for Americans" and particularly applauds its inclusion of specific advice for older adults.

4 Feb 2011

Cognitive behavioral therapy more effective than antidepressant medications for bulimia nervosa

A new evidence report by ECRI Institute comparing the effectiveness of various treatments for bulimia nervosa indicates that cognitive behavioral therapy is more effective than antidepressant medications and supportive therapies in improving eating disorder symptoms.

2 Feb 2011

Baxter launches OLIMEL emulsion for parenteral nutrition

Baxter International today announced the launch of OLIMEL emulsion for infusion in Canada at the American Society of Parenteral and Enteral Nutrition's Clinical Nutrition Week.

From Baxter International Inc. 31 Jan 2011

Study examines link between media consumption, eating disorders among adolescent girls in Fiji

For parents wanting to reduce the negative influence of TV on their children, the first step is normally to switch off the television set. But a new study suggests that might not be enough. It turns out indirect media exposure, i.e., having friends who watch a lot of TV, might be even more damaging to a teenager's body image.

7 Jan 2011

Research provides new insights into eating disorders in Native Americans

The research, published in the International Journal of Eating Disorders, provides new insights into the extent to which Native American populations experience eating disorders, revealing that women are more likely to report behavioral symptoms then men, while challenging views that NA men and ethnically white men will experience different psychological symptoms.

7 Jan 2011

Way of experiencing internal state of body influences perception of body from the outside

A new study, led by Dr Manos Tsakiris from Royal Holloway, University of London, suggests that the way we experience the internal state of our body may also influence how we perceive our body from the outside, as for example in the mirror. The research appears today (5 January) in the Proceedings of the Royal Society B.

5 Jan 2011

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Celgene International Sàrl announced regulatory submissions for its blood cancer therapies REVLIMID (lenalidomide) and ISTODAX (romidepsin).

5 Jan 2011

Vicus initiates VT-122 Phase 2 trial in advanced liver cancer, systemic inflammation and cachexia

Vicus Therapeutics, LLC, today announced the initiation of a Phase 2 trial evaluating VT-122, a novel investigational combination of etodolac and propranolol, and Nexavar® (sorafenib) tablets, as a potential new treatment option for patients with advanced liver cancer (hepatocellular carcinoma), systemic inflammation and cachexia.

28 Dec 2010

Fat or obese – What’s in a name?

The question of whether the term ‘fat’ is more appropriate than ‘obese’ was raised in an Australian study that confirmed the former is the “lesser of two evils”. The study from University of NSW study which looked at public perceptions surrounding these words has found that, while both are unwelcome, obese was viewed more negatively.

13 Dec 2010

Alkermes announces preliminary results from ALKS 33 Phase 2 study in alcohol dependence

Alkermes, Inc. today announced preliminary results from a phase 2 clinical study of ALKS 33, one of Alkermes' proprietary candidates for the treatment of reward disorders and other central nervous system (CNS) disorders. The 12-week study was designed to assess the safety and efficacy of daily oral administration of three different dose levels of ALKS 33 compared to placebo in 400 alcohol dependent patients.

9 Dec 2010

Eating Disorders News and Research

Latest Eating Disorders News and Research

Vertex announces positive interim results from telaprevir Phase 2 study in patients with HCV, HIV

Brain's reward/motivation circuits linked to compulsive overeating

Onyx, Bayer initiate patient enrollment in Nexavar Phase 3 trial for breast cancer treatment

New study: Cannabis ingredient can improve appetites and sense of taste in cancer patients

Online Negative Enabling Support Group embraces anorexia as a choice

Eating tissue to stay thin

Study: Women with anorexia draw themselves with prominently different characteristics

Urocortin system plays central role in regulating stress responses

Study reveals Facebook users may face risk of developing eating disorders

Phase II results of VELCADE in patients with aggressive lymphoma published in Journal of Clinical Oncology

GSA commends '2010 Dietary Guidelines for Americans'

Cognitive behavioral therapy more effective than antidepressant medications for bulimia nervosa

Baxter launches OLIMEL emulsion for parenteral nutrition

Study examines link between media consumption, eating disorders among adolescent girls in Fiji

Research provides new insights into eating disorders in Native Americans

Way of experiencing internal state of body influences perception of body from the outside

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Vicus initiates VT-122 Phase 2 trial in advanced liver cancer, systemic inflammation and cachexia

Fat or obese – What’s in a name?

Alkermes announces preliminary results from ALKS 33 Phase 2 study in alcohol dependence

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eating Disorders News and Research

Latest Eating Disorders News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in